Related Experiment Video
Updated: May 1, 2026

10:10
Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
Published on: November 13, 2021
9.1K
DESIGN OF IMMUNORADIOMETRIC ASSAY FOR GONADOTROPINS USING A COMMON DETECTION ANTIBODY: AN EXPERIENCE
P C Vrinda1, S N Paradkar, G Samuel
1a Radiopharmaceutical Programme, Board of Radiation and Isotope Technology (BRIT), Department of Atomic Energy, BARC Vashi Complex , Navi Mumbai , India.
Journal of Immunoassay & Immunochemistry
|March 25, 2014
Summary
We developed a new immunoradiometric assay for gonadotropins Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). This assay demonstrates high sensitivity and precision, making it clinically useful for hormone level measurement.
Area of Science:
- Biochemistry
- Immunology
- Endocrinology
Background:
- Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) are critical gonadotropins regulating reproductive functions.
- Accurate measurement of FSH and LH is essential for diagnosing various endocrine and reproductive disorders.
- Existing assay methods may have limitations in sensitivity, precision, or cross-reactivity.
Purpose of the Study:
- To develop and validate a novel immunoradiometric assay (IRMA) for simultaneous measurement of FSH and LH.
- To utilize a common tracer strategy for enhanced assay efficiency.
- To establish the clinical utility of the developed assay through rigorous validation.
Main Methods:
- Development of a common tracer by radiolabeling a monoclonal antibody against a common epitope of FSH and LH.
- Chemical immobilization of epitope-specific monoclonal antibodies against the β-subunit of FSH and LH as the capture system.
- Optimization of an inclusive assay procedure involving incubation of standards/samples with the capture antibody and common tracer.
Main Results:
- The developed IRMA achieved a sensitivity of 1.0 mIU/ml for both FSH and LH.
- Assay precision was acceptable, with an imprecision coefficient of variation (CV) ≤ 10%.
- Minimal cross-reactivity was observed, indicating assay specificity.
Conclusions:
- The developed common tracer-based IRMA for FSH and LH is a clinically useful assay.
- The assay offers adequate sensitivity, acceptable precision, and minimal cross-reactivity.
- This method provides a reliable tool for accurate gonadotropin measurement in clinical settings.

